Search for drugs:
Typing the drug name to query
AMINOLEVULINIC ACID HYDROCHLORIDE
DIR Classification
Classification:Ambiguous
Severity Score:1.0
Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF
- CLINICAL PHARMACOLOGY
- Pharmacodynamics
- Cardiac Electrophysiology
- Administration of the approved recommended dose of Gleolan did not prolong the QT interval to any clinically relevant extent.
Postmarketing Surveillance
Contingency Table:
Current Drug
Other Drugs
QT Prolongation
0
24092
Other ADRs
0
38381587
Odds Ratio = N/A
Drug Property Information
ATC Code(s):
- L01XD04 - aminolevulinic acid hydrochloride
- L01XD0 -
- L01XD - Sensitizers used in photodynamic/radiation therapy
- L01X - OTHER ANTINEOPLASTIC AGENTS
- L01 - ANTINEOPLASTIC AGENTS
- L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Active Ingredient:AMINOLEVULINIC ACID HYDROCHLORIDE
Active Ingredient UNII:V35KBM8JGR
Drugbank ID:DB00855
PubChem Compound:137
CTD ID:D000622
PharmGKB:PA10015
CAS Number:106-60-5
Dosage Form(s):powder, for solution
Route(s) Of Administrator:oral
Daily Dose:
Chemical Structure: 
SMILE Code:
NCC(=O)CCC(O)=O
NCC(=O)CCC(O)=O
Reference
N/A
Disclaimer:
The content of this database of QT prolongation is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.
Any mention of commercial products is for clarification and not intended as endorsement.